Face to Face Hot Stocks: Arthur J. Gallagher & Co. (NYSE:AJG), China Pharma Holdings, Inc. (NYSE:CPHI)

Arthur J. Gallagher & Co. (NYSE:AJG)

Arthur J. Gallagher & Co. (NYSE:AJG) closed at $91.81 on the last trading session with an decrease of -0.21%, whereas, it previously closed at $92. The company has a market capitalization of $16.92 Billion. The company traded shares of 1.33 Million on the trading day while its three month average volume stands at 948.82 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Arthur J. Gallagher & Co. (NYSE:AJG) produced diluted EPS of 3.78. The EPS estimate for next year as estimated by analysts is at 4.24 while EPS for next quarter is estimated at 0.82. Earnings per Share growth for this year is reported at 21.3, while the analysts estimated the EPS growth for next year at 4.24% and Earnings growth for next 5 years stands at 10.22% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 10.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Arthur J. Gallagher & Co. (NYSE:AJG) is at 24.28 while the forward p/e is at 21.64. The P/S or Price to Sales ratio of Arthur J. Gallagher & Co. (NYSE:AJG) stands at 2.39 and Price to Book or P/B for the most recent quarter stands at 3.47. The Price to Free Cash Flow ratio or P/FCF is reported at 49.93. The quick ratio and the current ratio of Arthur J. Gallagher & Co. (NYSE:AJG) are reported at 1.1 and 1.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Arthur J. Gallagher & Co. (NYSE:AJG) stands at 3.8, 13.8 and 10.2 respectively

The trailing twelve month Revenue of Arthur J. Gallagher & Co. (NYSE:AJG) is reported at 7.09 Billion with income of 709 Million. The outstanding shares of Arthur J. Gallagher & Co. (NYSE:AJG) are 184.29 Million. The institutional Ownership of the shares of 86.1 stands at 0.80%, this figure is decreased -0.6 in the last six months. The insider ownership for the shares of Arthur J. Gallagher & Co. (NYSE:AJG) is ticked at 0.4%, the figure is plummeted -6.8% in the last six months.

Some other important financial aspects to be discussed here for Arthur J. Gallagher & Co. (NYSE:AJG) is the Mean Target Price estimated by the analysts which stands at 93.36. The 52 week high of Arthur J. Gallagher & Co. (NYSE:AJG) is placed at 92.74 and 52 week low is standing at 68.19.

Performance wise the shares of Arthur J. Gallagher & Co. (NYSE:AJG) fell down -0.15% for the week, it also rise 4.82% for the monthly performance, while for the quarter it went down 9.79%. The shares increase 27.66% for the half year and flew up for the Year-To-Date performance. The shares of Arthur J. Gallagher & Co. (NYSE:AJG) grew 29.51% for the yearly performance.

China Pharma Holdings, Inc. (NYSE:CPHI)

China Pharma Holdings, Inc. (NYSE:CPHI) closed at $0.29 on the last trading session with an decrease of -3.26%, whereas, it previously closed at $0.3. The company has a market capitalization of $12.58 Million. The company traded shares of 143653 on the trading day while its three month average volume stands at 310.56 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of China Pharma Holdings, Inc. (NYSE:CPHI) produced diluted EPS of -0.25. The EPS estimate for next year as estimated by analysts is at 0 while EPS for next quarter is estimated at 0. Earnings per Share growth for this year is reported at 44.2, while the analysts estimated the EPS growth for next year at 0% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 11.7%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of China Pharma Holdings, Inc. (NYSE:CPHI) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of China Pharma Holdings, Inc. (NYSE:CPHI) stands at 1.08 and Price to Book or P/B for the most recent quarter stands at 0.41. The Price to Free Cash Flow ratio or P/FCF is reported at 17.97. The quick ratio and the current ratio of China Pharma Holdings, Inc. (NYSE:CPHI) are reported at 0.4 and 0.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for China Pharma Holdings, Inc. (NYSE:CPHI) stands at -21.6, -31.2 and -27.1 respectively

The trailing twelve month Revenue of China Pharma Holdings, Inc. (NYSE:CPHI) is reported at 11.6 Million with income of -10900000. The outstanding shares of China Pharma Holdings, Inc. (NYSE:CPHI) are 43.67 Million. The institutional Ownership of the shares of 96.8 stands at 0.80%, this figure is increased 0 in the last six months. The insider ownership for the shares of China Pharma Holdings, Inc. (NYSE:CPHI) is ticked at 0.3%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for China Pharma Holdings, Inc. (NYSE:CPHI) is the Mean Target Price estimated by the analysts which stands at 0. The 52 week high of China Pharma Holdings, Inc. (NYSE:CPHI) is placed at 0.84 and 52 week low is standing at 0.19.

Performance wise the shares of China Pharma Holdings, Inc. (NYSE:CPHI) fell down -0.31% for the week, it also fell -10.95% for the monthly performance, while for the quarter it went up -13.51%. The shares increase 4.73% for the half year and flew up for the Year-To-Date performance. The shares of China Pharma Holdings, Inc. (NYSE:CPHI) grew 10.77% for the yearly performance.